Referens 7

I tidningen Biogenic Amines, G. Ali Qureshi och medarbetare sammanfattade under »Future Clinical Implications«

»On the basis of future results on MS, the role of various neurotransmitters, free radicals and metals, it may be possible to develop symptomatic therapy with agonists or antagonists«

Qureshi, G.A., Halawa,A.Baig,S. and Sidén,Å., »Multiple Sclerosis and neurotransmission«, Biogenic Amines 1996:12(5) pp.353-376